MedPath

Fomepizole

Fomepizole Injection, 1.5 grams per 1.5 mL (1 gram per mL)(For Intravenous Infusion Only)Sterile

Approved
Approval ID

1dea37fd-ec17-416e-b28e-980a87d49e1a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 26, 2023

Manufacturers
FDA

Sagent Pharmaceuticals

DUNS: 080579617

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fomepizole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code25021-829
Application NumberANDA216791
Product Classification
M
Marketing Category
C73584
G
Generic Name
Fomepizole
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 19, 2023
FDA Product Classification

INGREDIENTS (1)

FomepizoleActive
Quantity: 1.5 g in 1.5 mL
Code: 83LCM6L2BY
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fomepizole - FDA Drug Approval Details